Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase

Paul D. Jones, Hsing Ju Tsai, Zung N. Do, Christophe Morisseau, Bruce D. Hammock

Research output: Contribution to journalArticle

70 Scopus citations

Abstract

A series of conformationally restricted inhibitors of human soluble epoxide hydrolase (sEH) has been developed. Inhibition potency of the described compounds ranges from 4.2 μM to 1.1 nM against recombinant sEH. N-(1-Acetylpiperidin-4-yl)-N′-(adamant-1-yl) urea (5a) was found to be a potent inhibitor (IC50 = 7.0 nM) that was also orally bioavailable in canines.

Original languageEnglish (US)
Pages (from-to)5212-5216
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume16
Issue number19
DOIs
StatePublished - Oct 1 2006

Keywords

  • Enzyme inhibition
  • Soluble epoxide hydrolase
  • Structure-activity relationships

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase'. Together they form a unique fingerprint.

  • Cite this